Security key
92859E207
Vivos Therapeutics, Inc. - Common Stock, par value $0.0001 per share (VVOS)
CUSIP: 92859E207
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 186,896
- Total 13F value
- $433,846
- Share change
- -78,267
- SEC-reported price per share
- $2.22
- Number of holders
- 18
- Value change
- -$444,091
- Number of buys
- 8
- Number of sells
- 3
- Shares outstanding
- 13,985,437
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
18
Top holders
10
VVOS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Vivos Therapeutics, Inc. SEC filings
Vivos Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92859E207
Recent filing periods:
Ownership snapshot
Top reported holders of VVOS - Vivos Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 0.74%
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 0.74%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
0.74%
COMMONWEALTH EQUITY SERVICES, LLC
0.11%
VANGUARD GROUP INC
0.08%
CREDIT AGRICOLE S A
0.02%
NFSG Corp
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
0.74%
|
$500,301
103,582 shares
|
— | 31 Mar 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
Company
|
0.11%
|
$72,000
15,000 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.08%
|
$51,097
10,579 shares
|
— | 31 Mar 2024 |
| CREDIT AGRICOLE S A |
13F
Individual
|
0.02%
|
$63
2,365 shares
|
— | 31 Mar 2024 |
| NFSG Corp |
13F
Company
|
0.01%
|
$9,419
1,950 shares
|
— | 31 Mar 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.01%
|
$8,351
1,729 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
18
Shares
186,896
Rows available
18
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2026 Across Filers
Q1 2026 holders
23
Q2 2024 holders
18
Holder diff
-5
| Investor | Q1 2026 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend